Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.
about
Polycythemia Vera Management and Challenges in the Community Health Setting.The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents.Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms.Low-dose methotrexate in myeloproliferative neoplasm models.
P2860
Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Changes in quality of life and ...... xolitinib or standard therapy.
@en
type
label
Changes in quality of life and ...... xolitinib or standard therapy.
@en
prefLabel
Changes in quality of life and ...... xolitinib or standard therapy.
@en
P2093
P2860
P50
P356
P1476
Changes in quality of life and ...... xolitinib or standard therapy.
@en
P2093
Alessandro M Vannucchi
Claire N Harrison
Fabrizio Pane
Huiling Zhen
Isabelle Côté
Jingjin Li
Mark M Jones
Martin Griesshammer
Ruben Mesa
P2860
P304
P356
10.1111/EJH.12707
P577
2015-11-26T00:00:00Z